Identifying prognostic subgroups for outcomes in BRAF(V600)-mutated metastatic melanoma patients (pts) treated with vemurafenib (V) ± cobimetinib (C): A pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM Meeting Abstract
| Authors: | Larkin, J. M. G.; Ribas, A.; Flaherty, K.; McArthur, G. A.; Ascierto, P. A.; Dréno, B.; Lewis, K. D.; Chapman, P. B.; McKenna, E. F.; Zhu, Q.; Mun, Y.; Hauschild, A. |
| Abstract Title: | Identifying prognostic subgroups for outcomes in BRAF(V600)-mutated metastatic melanoma patients (pts) treated with vemurafenib (V) ± cobimetinib (C): A pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 493s |
| Language: | English |
| ACCESSION: | WOS:000404711507158 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.9536 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9536 -- Source: Wos |
